Modified lipoproteins as contrast agents for molecular imaging

Future Lipidology

Volumn 2, Issue 6, 2007, Pages 587-590

  Cormode, David P ^a   Mulder, Willem J M ^a   Fisher, Edward A ^b,c   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOPHILE; ANTIBODY; APOLIPOPROTEIN; CHELATING AGENT; CHOLESTEROL ESTER; CONTRAST MEDIUM; FLUORINE; GADOLINIUM; HIGH DENSITY LIPOPROTEIN; IODINE 123; LIPID; LIPOPROTEIN; LIPOSOME; LOW DENSITY LIPOPROTEIN; NANOPARTICLE; PEPTIDE; PHOSPHOLIPID; POLYETHER; TECHNETIUM 99M; TRIACYLGLYCEROL;

DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DRUG DESIGN; EARLY DIAGNOSIS; EDITORIAL; FLUORESCENCE; HUMAN; MICROEMULSION; MOLECULAR IMAGING; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIODIAGNOSIS;

EID: 37549018115     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460875.2.6.587     Document Type: Editorial

References (23)

1. Weissleder R, Mahmood U: Molecular imaging. Radiology 219, 316-333 (2001).
2. Amirbekian V, Lipinski MJ, Briley-Saebo KC et al.: Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc. Natl Acad. Sci. USA 104, 961-966 (2007).
3. Lipinski MJ, Amirbekian V, Frias JC et al.: MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn. Reson. Med. 56, 601-610 (2006).
4. Mulder WJ, Strijkers GJ, Griffioen AW et al.: Liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug. Chem. 15, 799-806 (2004).
5. Lanza GM, Winter PM, Caruthers SD et al.: Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. Nanomedicine 1, 321-329 (2006).
6. Kim BS, Qiu JM, Wang JP. Taton TA: Magnetomicelles: composite nanostructures from magnetic nanoparticles and cross-linked amphiphilic block copolymers. Nano Lett. 5(10), 1987-1991 (2005).
7. Mulder WJM, Griffoen AW, Strijkers GJ, Cormode DP, Nicolay KA, Fayad, ZA: Magnetic and fluorescent nanoparticles for multimodality imaging. Nanomedicine 2(3) 307-324 (2007).
8. 3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 2103-2109 (2006).
9. Torchilin VP: Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4, 145-160 (2005).
10. Frias JC, Williams KJ, Fisher EA, Fayad ZA: Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J. Am. Chem. Soc. 126, 16316-16317 (2004).
11. Frias JC, Ma Y, Williams KJ, Fayad ZA, Fisher EA: Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett. 6, 2220-2224 (2006).
12. Zheng G, Chen J, Glickson, JD: Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc. Natl Acad. Sci. USA 102, 17757-17762 (2005).
13. Ahrens ET, Flores R, Xu H, Morel PA: In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 23(8), 945-946 (2005).
14. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353 (1955).
15. Lusis AJ: Atherosclerosis. Nature 407, 233-241 (2000).
16. 123I-low density lipoprotein. Eur. J. Nucl. Med. 12, 291-292 (1986).
17. Sinzinger H, Angelberger P: Imaging and kinetic studies with radiolabeled autologous low-density lipoproteins (LDL) in human atherosclerosis. Nucl. Med. Commun. 9, 859-866 (1988).
18. 99mtechnetium labelled oxidized LDL in man. Atherosclerosis 126, 131-141 (1996).
19. Chen J, Corbin IR, Li H, Cao W, Glickson JD, Zheng G: Ligand conjugated low-density lipoprotein nanoparticics for enhanced optical cancer imaging in vivo. J. Am. Chem. Soc. 129, 5798-5799 (2007).
20. Corbin IR, Li H, Chen J et al.: Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents. Neoplasia 8, 488-498 (2006).
21. Nichols AV, Krauss RM, Musliner TA: Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 128, 417-431 (1986).
22. 125I-BSA. Pathobiology 69, 225-229 (2001).
23. Cormode DP, Briley-Saebo KC, Mulder WJM et al.: Arterial macrophage imaging via an HDL mimetic peptide-based contrast agent. Presented at: Academy of Molecular Imaging (AMI) & Society for Molecular Imaging (SMI) Joint Molecular Imaging Conference. Providence, RI, USA, September 8-11 (2007) (Abstract 0722).